Washington University School of Medicine
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Washington University School of Medicine sits in the top decile of US sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count).
Washington University School of Medicine: 1,502 sponsored US clinical trials, 214 recruiting.
Washington University School of Medicine sponsors 1,502 registered US clinical trials on ClinicalTrials.gov, 214 of them currently recruiting, and 919 completed. 98 of these trials are in Phase 3-4 (later-stage) and 569 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 20 trials.
Top-decile sponsor footprint
Washington University School of Medicine ranks in the top decile of sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
919 of 1,159 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,502 total, page 18 of 31
Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer
NCT02546531
Tranexamic Acid Mechanisms and Pharmacokinetics in Traumatic Injury
NCT02535949
Local Ablative Strategies After Endovascular Radioembolization
NCT02611661
The Impact Of The Addition Of Budesonide To Low-Pressure, High-Volume Saline Sinus Irrigation For Chronic Rhinosinusitis
NCT02696850
Improving Follow-Up for Discharged Emergency Care Patients
NCT03002311
Persistent Pain After Cystectomy for Bladder Cancer
NCT02751346
Pneumonia in the Intensive Care Unit (ICU) Setting
NCT02685930
Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma
NCT02510950
MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer
NCT02582931
Shared Decision Making in Older Adults With Distal Radius Fractures
NCT02782299
Postoperative Delirium: Brain Vulnerability and Recovery
NCT03110185
Development of a Self- Management Program for Parents With Spinal Cord Injury and Disease
NCT03985553
Pilot - Peri-operative Beta Blockade
NCT02746575
Manual Versus Electric Vacuum Aspiration for Pregnancy Termination Between 10-14 Weeks
NCT03079622
Video Capsule Endoscopy Versus Colonoscopy in Patients With Melena and Negative Upper Endoscopy
NCT02609100
Effects of RLIC on Motor Learning in Middle-aged and Older Adults
NCT03582943
Bright Light on Fatigue in Women Being Treated for Breast Cancer
NCT02658708
Everolimus in Patients With Advanced Solid Malignancies With TSC1, TSC2, NF1, NF2, or STK11 Mutations
NCT02352844
The Predictive Value of Ureteral Jet Assessment With Ultrasound in Patients Presenting With Acute Renal Colic
NCT02577146
Prophylactic Incisional Care in Obese Women at Cesarean
NCT02578745
Staph Household Intervention for Eradication (SHINE)
NCT02572791
Roux-en-Y Gastric Bypass and Weight Regain
NCT02302898
IVF in Pediatric Concussion
NCT02214316
Pacritinib to Inhibit JAK/STAT Signaling in Refractory Colorectal Cancer
NCT02277093
Genomic Landscape of Ceritinib
NCT02554591
SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer
NCT02562027
Flexibility of Cognition And Persistent Pain
NCT02579538
Naloxone for Optimizing Hypoxemia Of Lung Donors
NCT02581111
Supporting Decisions About Health Insurance to Improve Care for the Uninsured
NCT02522624
Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma
NCT02352831
CNS Tau Kinetics in Healthy Aging and Alzheimer's Disease
NCT03938870
Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors
NCT02372409
MK-3475 in Combination With MRI-guided Laser Ablation in Recurrent Malignant Gliomas
NCT02311582
Vaginal Cleansing Before Cesarean Delivery to Reduce Infection
NCT02495753
Thromboelastography Transfusion Protocol for Pediatric Neuromuscular Scoliosis Surgery
NCT02670798
Peer-Led Healthy Lifestyle Program in Supportive Housing
NCT02175641
Trendelenberg Versus Left Lateral Position for Colonoscopy
NCT02519686
Safety and Immunogenicity of a Personalized Polyepitope DNA Vaccine Strategy in Breast Cancer Patients With Persistent Triple-Negative Disease Following Neoadjuvant Chemotherapy
NCT02348320
Study of CLAG + Selinexor in Relapsed or Refractory Acute Myeloid Leukemia
NCT02416908
Afatinib Genomic Landscape
NCT02491775
fPAM for the in Vivo Depth Measurement of Pigmented Lesions and Melanoma Depth
NCT02613325
Evaluating Strategies to Present Colon Cancer Screening Information
NCT02485561
Genetically Informed Smoking Cessation Trial
NCT02351167
Pacritinib in Patients With Endothelial Growth Factor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) After EGFR Tyrosine Kinase Inhibitor (TKI)
NCT02342353
Nintedanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer
NCT02299141
Diabetes Group Prenatal Care
NCT02444325
Genomic Landscape of EGFR Mutant NSCLC Prior to Erlotinib and at the Time of Disease Progression
NCT02431169
Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography
NCT02455453
Pazopanib in Molecularly Selected Patients With Advanced NSCLC
NCT02193152
Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Standard Therapies
NCT02369458
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 332 |
| Phase 2 | 237 |
| Phase 3 | 40 |
| Phase 4 | 58 |
Therapeutic Areas
What is open in the Washington University School of Medicine pipeline
214 recruiting of 1,502 indexed (14% open); 919 completed (61%).
Phase mix: 98 late (III/IV) vs 569 early (I/II) (early-phase heavy).
Top condition: Obesity (20 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Washington University School of Medicine: open-pipeline peers nationwide
Peers matched on 1,502 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,502 trials (± recruiting share)
- Yale University · 1,492 trials · 17% recruiting
- Johns Hopkins University · 1,448 trials · 17% recruiting
- University of Pennsylvania · 1,423 trials · 14% recruiting
- Novartis Pharmaceuticals · 1,375 trials · 8% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Academic and Community Cancer Research United · 14% recruiting · 42 trials
- Adaptive Biotechnologies · 14% recruiting · 7 trials
- AgelessRx · 14% recruiting · 7 trials
- Alaska Blind Child Discovery · 14% recruiting · 7 trials
Related
What to do with this Washington University School of Medicine page
1,502 registered trials is a research-attention snapshot, not an endorsement of Washington University School of Medicine or any single study.
- 214 of Washington University School of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Washington University School of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Washington University School of Medicine pipeline card: 1,502 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.